Your TRT Clinic Didn't Check the One Hormone That Matters Most

Your testosterone came back low. The clinic handed you a prescription. And nobody asked why it was low in the first place.

That is the problem worth understanding.

To understand it, you need the full map first. Your brain runs a signaling chain called the HPG axis, which is the hormonal pathway that starts in the hypothalamus, runs through the pituitary gland, and ends at the testes. The hypothalamus sends a signal called GnRH, which tells the pituitary to release something called LH, which travels to the testes and tells the Leydig cells to produce testosterone. That is the whole chain. Three steps, three places where things can go wrong.

Now here is where the thyroid comes in.

Your thyroid produces two hormones. One is called T4, which is the storage form, meaning your body keeps it in reserve but cannot use it directly. The other is called T3, which is the active form, the one your cells can actually respond to. To get from T4 to T3, your body runs a conversion process through enzymes called deiodinases, which strip one iodine molecule off T4 to create usable T3.

That conversion step matters more than most people realize, and it is also where deficiencies can silently break the system.

Once you have active T3, it does not just regulate your thyroid function. It reaches into the testosterone production system at three separate points, and if T3 is low, all three of those points begin to fail.

The first is at the pituitary. T3 modulates how well the pituitary responds to the GnRH signal coming from the hypothalamus. When thyroid function is low, the pituitary receives the signal but does not amplify it with enough strength, so LH output drops, and the testes get a quieter instruction to produce testosterone than they should. The result looks like a pituitary problem from the outside, but the actual cause is thyroid.

The second point is inside the Leydig cells themselves. This is where the mechanism gets specific. To produce testosterone, Leydig cells need cholesterol delivered into the mitochondria, because that is where the conversion chain begins. The protein responsible for that delivery is called StAR protein, which stands for steroidogenic acute regulatory protein, and it functions as the rate-limiting step in the entire process. Think of it as the door that cholesterol has to pass through before any testosterone can be made. T3 directly controls how much StAR protein gets expressed. Research in mouse Leydig cells found that T3 increased StAR protein expression by 260 percent, which means without adequate T3, the door stays mostly closed regardless of how much raw material is available. The workers are there and the cholesterol is there, but the machinery is not running.

The third point is the liver. Your liver produces something called SHBG, which stands for sex hormone binding globulin, and its job is to bind to testosterone in the bloodstream and make it unavailable for the body to use. Only free testosterone, the portion not bound to SHBG, can actually interact with your cells and produce effects. Thyroid hormones regulate how much SHBG the liver produces, and when thyroid function is low, SHBG tends to rise, which means even whatever testosterone does get produced ends up less available than it should be.

So you have suppressed LH output, a slower steroidogenic process inside the Leydig cell, and higher SHBG binding the testosterone that does get made. Any one of those alone would reduce your numbers. All three together make a significant depression in both total and free testosterone.

This is not theoretical. A study published in Clinical Endocrinology looked at men with primary hypothyroidism and measured their free testosterone before and after treatment with thyroxine. Before treatment, free testosterone averaged 161 pmol/L. After thyroid hormone replacement alone, with no testosterone therapy added, free testosterone nearly doubled to 315 pmol/L. The only intervention was restoring thyroid function.

That is the data point that makes the clinic workflow look like a problem.

When a man comes in with low testosterone, the standard response in most TRT clinics is to confirm the low number and prescribe replacement. What that workflow skips is the question of why the number is low, and the thyroid is one of the most common and most correctable reasons. Treating low testosterone with TRT when the underlying cause is hypothyroidism does address the symptom, but it leaves the root mechanism running, and it commits you to a therapy you may not have needed.

Now, the conversion step between T4 and T3 introduces one more layer worth knowing. Those deiodinase enzymes that convert T4 into active T3 require selenium to function. Selenium is a trace mineral, and deficiency is more common than most people expect, particularly in regions with selenium-poor soil. Research published in BMC Endocrine Disorders found that selenium deficiency is directly associated with impaired T4 to T3 conversion, showing up as a high free T4 to T3 ratio, meaning the storage hormone is available but the body is not converting it efficiently. The result is a form of functional low T3 even when TSH looks normal, and downstream from that, suppressed testosterone through all three mechanisms above.

This is why a TSH test alone is not enough. TSH reflects whether the thyroid is being asked to work harder, but it does not tell you whether the conversion to active T3 is completing properly. A full panel means TSH, free T4, free T3, and reverse T3, which is the inactive form of T3 that competes with active T3 at the receptor level and can suppress its effects even when total T3 looks acceptable.

If those numbers reveal a conversion problem, the first intervention is not a prescription. It is checking selenium, addressing the deficiency, and retesting. If the thyroid itself is underactive, thyroxine replacement has a documented track record of restoring testosterone to normal range without touching the HPG axis directly.

The testosterone number your clinic tested is real. But a number without a cause is just a prompt to prescribe, and the cause is the part that determines whether the prescription was ever the right answer.

---

References

1. Donnelly P, White C. 2000. Testicular dysfunction in men with primary hypothyroidism; reversal of hypogonadotrophic hypogonadism with replacement thyroxine. Clinical Endocrinology, 522:197-201. Free testosterone nearly doubled 161 to 315 pmol/L after thyroxine replacement. Source
2. Maran RR, et al. 2000. Assessment of mechanisms of thyroid hormone action in mouse Leydig cells. Endocrinology, 14112:4468-4477. T3 increases LH receptor numbers and StAR protein expression 260% increase in Leydig cells. Source
3. Krassas GE, et al. 2010. The male and female reproductive systems in hypothyroidism. Thyroid hormones modulate HPG axis at multiple levels including pituitary LH response, direct Leydig cell effects, and SHBG regulation. Source
4. Winther KH, et al. 2020. Thyroid function in patients with selenium deficiency exhibits high free T4 to T3 ratio. BMC Endocrine Disorders. Selenium deficiency directly associated with impaired T4 to T3 conversion. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness